Workshop on Vulnerability Assessment, Online, European Medicines Agency, Amsterdam, the Netherlands, from 18 March 2026, 09:30 (CET) to 18 March 2026, 12:30 (CET)
Veterinary medicines European public assessment report (EPAR): Emepax, maropitant, Status: Authorised
PSUSA/00002540/202509
Veterinary medicines European public assessment report (EPAR): AviGate S. Infantis, Salmonella Infantis vaccine (live), Status: Authorised
Veterinary medicines European public assessment report (EPAR): VeroBlue-3, bluetongue virus vaccine (inactivated), Status: Authorised
EMA welcomes political agreement on Critical Medicines Act
Template for response to list of questions/list of outstanding issues: Quality / Non-clinical / Clinical
Human medicines European public assessment report (EPAR): Tobi Podhaler, tobramycin, Date of authorisation: 20/07/2011, Revision: 25, Status: Authorised
Human medicines European public assessment report (EPAR): Imuldosa, ustekinumab, Date of authorisation: 12/12/2024, Revision: 6, Status: Authorised
PSUSA/00002702/202509